PT - JOURNAL ARTICLE AU - Petrovic, Dusan AU - Carmeli, Cristian AU - Sandoval, José Luis AU - Bodinier, Barbara AU - Chadeau-Hyam, Marc AU - Schrempft, Stephanie AU - Ehret, Georg AU - Dhayat, Nasser Abdalla AU - Ponte, Belén AU - Pruijm, Menno AU - Dermitzakis, Emmanouil AU - Vineis, Paolo AU - Gonseth-Nusslé, Sémira AU - Guessous, Idris AU - McCrory, Cathal AU - Bochud, Murielle AU - Stringhini, Silvia TI - Life-course socioeconomic factors are associated with markers of epigenetic aging in a population-based study AID - 10.1101/2022.06.16.22276489 DP - 2022 Jan 01 TA - medRxiv PG - 2022.06.16.22276489 4099 - http://medrxiv.org/content/early/2022/06/16/2022.06.16.22276489.short 4100 - http://medrxiv.org/content/early/2022/06/16/2022.06.16.22276489.full AB - Adverse socioeconomic circumstances negatively affect the functioning of biological systems, but the underlying mechanisms remain only partially understood. Here, we explore the associations between life-course socioeconomic factors and four markers of epigenetic aging in a population-based setting.We used data from a population-based study conducted in Switzerland (SKIPOGH) to assess the association between childhood, adulthood, and life-course socioeconomic indicators, and blood-derived markers of epigenetic aging (Levine’s, DunedinPoAm38, GrimAge epigenetic age acceleration (EAA) and the mortality risk score (MS)). We used mixed regression to explore the associations between socioeconomic indicators and markers of epigenetic aging independently, and counterfactual mediation to investigate the mechanisms underlying the life-course socioeconomic gradient in epigenetic aging.Individuals reporting a low father’s occupation, adverse financial conditions in childhood, a low income, having financial difficulties, or experiencing unfavorable socioeconomic trajectories were epigenetically older than their more advantaged counterparts. Specifically, this corresponded to an average increase of 1.0-1.5 years for Levine’s epigenetic age when compared to chronological age, 1.1-1.5 additional years for GrimAge, 5%-8% higher DunedinPoAm38 EAA, and 2%-5% higher MS score. By exploring the life-course mechanisms underlying the socioeconomic gradient in epigenetic aging, we found that both childhood and adulthood socioeconomic factors contributed to epigenetic aging, and that detrimental lifestyle factors mediated the relation between socioeconomic circumstances in adulthood and EAA.Our study provides novel empirical evidence for a “sensitive-period” life-course model, whereby adverse socioeconomic circumstances in childhood and adulthood negatively affected epigenetic aging. Counterfactual mediation analyses further showed that the effect of socioeconomic factors in adulthood operated through detrimental lifestyle factors, whereas associations involving early-life socioeconomic factors were less clear.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Lifepath project, which is funded by the European commission (Horizon 2020 grant 633666), the Swiss state secretariat for education, research and innovation (SERI), the Swiss National Science Foundation, the Medical Research Council and the Portuguese Foundation for Science. Silvia Stringhini was supported by the Ambizione PROSPER grant (Grant PZ00P3 147998) from the Swiss National Science Foundation. Dusan Petrovic was supported by the Doc.Mobility grant (Grant P1LAP3 178061) from the Swiss National Science Foundation. The SKIPOGH study is funded by a grant from the Swiss National Science Foundation (Grant 140331) and by intramural support of Lausanne, Geneva, and Bern University Hospitals. The funders hand no role in study design, data collection and analysis, manuscript writing, and in the decision to submit.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of the Geneva University Hospitals gave ethical approval for this work Ethics committee of the Lausanne University Hospital gave ethical approval for this work Ethics committee of the Bern University Hospital gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsBMIBody mass indexCIConfidence intervalCpGCytosine-phospho-Guanine dinucleotideDAGDirected acyclic graphDNADeoxyribonucleic acidDNAmPhenoAgeSecond generation phenotypic DNA methylation epigenetic clock (Levine)DunedinPoAmSecond generation Dunedin Pace of Aging Methylation epigenetic clockEAAEpigenetic age accelerationGrimAgeSecond generation GrimAge epigenetic clockMSMortality risk scoreMTEMarginal total effectNDENatural direct effectNIENatural indirect effectOROdds ratioPMProportion mediatedSDStandard deviationSESocioeconomic (factors)SKIPOGHSwiss Kidney Project on Genes in HypertensionWBCWhite blood cells